FORWARD BIOLABS INC (EIN 823817912) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2017

Legal Domicile

Principal Officer

JESSICA MARTIN ECKERLY

Phone

6085776625

Tax Period

2023-07-01 to 2024-06-30

FORWARD BIOLABS INC, founded in 2017, is a small nonprofit in the Science & Technology sector that reported $926K in total revenue in fiscal year 2023. Revenue grew 12% year-over-year, indicating healthy expansion. The organization ran a surplus of $153K, a strong 17% operating margin.

Mission

TO ACCELERATE TRANSLATIONAL RESEARCH, SPARK STATE-WIDE ECONOMIC DEVELOPMENT AND CREATE JOBS THROUGH OPERATING A FULLY-SUPPORTED, STATE-OF-THE ART LABORATORY TO BE SHARED BY INNOVATIVE, EARLY-STAGE BIOTECHNOLOGY COMPANIES ASSOCIATED WITH THE UNIVERSITY OF WISCONSIN-MADISON AND OTHER LIFE-SCIENCE RESEARCH ORGANIZATIONS. ADDITIONALLY, FORWARD BIOLABS PROVIDES EDUCATION AND MENTORING TO EARLY-STAGE, BIOTECHNOLOGY COMPANIES ENGAGED IN TRANSLATIONAL LIFE-SCIENCE RESEARCH.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $304,130

Program Service Revenue $616,896

Investment Income $5,161

Other Revenue $88

TOTAL REVENUE $926,275

Expense Breakdown

Grants Paid $0

Salaries & Benefits $439,850

Fundraising Expenses $5,445

Program Expenses $558,190

Other Expenses $333,074

TOTAL EXPENSES $772,924

Year-over-Year Comparison

	2023	2022	Change
Revenue	$926,275	$828,347	+0.1%
Expenses	$772,924	$608,683	+0.3%
Net Income	$153,351	$219,664	-0.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$241,024

Total Directors

$241,024

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JESSICA MARTIN ECKERLY	CEO & SECRETARY	40.00	Officer Director	$195,595	$45,429	$241,024
AARON OLVER	PRESIDENT	2.00	Officer Director	$0	$0	$0
ROBERT DRAPE	TREASURER	2.00	Officer Director	$0	$0	$0
PAM CHRISTENSON	DIRECTOR	1.00	Director	$0	$0	$0
MICHAEL PARTSCH	DIRECTOR	1.00	Director	$0	$0	$0
TOM LIVELLI	DIRECTOR	1.00	Director	$0	$0	$0
LISA JOHNSON	DIRECTOR	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$926,275	$772,924	$2,631,783	$153,351
2023	$828,347	$608,683	$2,436,964	$219,664
2022	$895,538	$610,598	$2,187,908	$284,940
2021	$1,288,327	$526,112	$2,153,879	$762,215
2020	$997,405	$550,400	$904,834	$447,005
2019	$384,424	$11,561	$383,376	$372,863

FORWARD BIOLABS INC